Accurate detection of IDH mutation and 1p/19q codeletion is important for risk stratification since these markers have predicative power for longer survival and distinguishing oligodendrogliomas from diffuse astrocytomas, respectively [2]. The gene discussed is IDH1; the disease is oligodendroglioma.